| 09.00-11.00.-
Round Table Discussion.- Looking for the best treatment for each
smoker (*)
(Paraninfo Room)
| Chairperson: |
Eva Kralikova |
| Speakers: |
Karl O. Fagerström
What diagnostic characteristics should we look for in smokers?
Robert West.
Nicotine Replacement Therapy
Martin Jarvis.
Bupropion
PeterHajek.
Behavioural therapy
|
| Objective: |
To give some practical information about when and where, to
whom and how to use the different pharmacological treatments
of smoking |
11.00-11.30.- Coffee Break – Commercial
Exhibition
11.30-12.30.-Debate: Harm Reduction (*)
(Paraninfo Room)
| Chairperson: |
Carlos A. Jiménez-Ruiz |
| Speakers: |
Pros: Philip Tønnesen
Cons: Richard Hurt
|
| Objective: |
The chair will make a short introduction of the issue. Then
each discussant will argue his position, followed by general
discussion. |
12.30-14.00.- Lunch - Poster Sesion I (Magdalena
Palace)
14.15-15.15.- Oral Presentations (Paraninfo
Room)
| Chairs: |
David Balfour and Eva Kralikova |
|
15.15-17.15.-Round Table Discussion. -
Anti-smoking Activities in Europe (Room
A)
| Chairperson: |
Peter Andersson. |
| Speakers: |
Joan Ramón Villalví
Prevention activities: the role of NGOs
H. Pardell
The role of local and regional governments
Enrique Gil
Legislative action on tobacco/nicotine in the EU
|
| Objective: |
To provide an outline of current tobacco control activities
|
15.15-17.15.- Round Table Discussion: Vulnerability
to tobacco dependence (*)
(Paraninfo Room)
| Chairperson: |
Dr. Andrew Johnston. |
| Speakers: |
Michael Murphy
Genetics underlying tobacco dependence in humans
Allan C. Collins
Genetics underlying psychopharmacological responses to
nicotine
David Balfour
Strain differences in mesoaccumbens dopamine responses
to nicotine
Martin Jarvis
Socio-economic influences on tobacco dependence
Lirio Covey
The role of psychopathology on tobacco dependence
|
| Objective: |
To provide an outline of innate and acquired factors affecting
tobacco dependence |
17.15-17.30.- Coffee Break – Commercial
Exhibition
17.30-19.00.-Round table discussion: Preventing
and treating relapse (*)
(Room B)
| Chairperson: |
Gay Sutherland. |
| Speakers: |
José Ignacio Granda-Orive
Relapsing as a learning process
Elisardo Becoña
Psycho-social relapse prevention
Andrew Johnston
Pharmacological relapse prevention
|
| Objective: |
To provide practical information on relapse and relapse-prevention.
|
17.30-19.00.-Round Table Discussion: Smoking
cessation in special populations (*)
(Room A)
| Chairperson: |
Agneta Nordberg. |
| Speakers: |
Peter Hajek
Treating pregnant smokers
Pedró J. Romero
Treating smokers with CVD
Karen Slama
Treating adolescents and children smokers
|
| Objective: |
To provide practical information on approaches to special
populations |
17.30-19.00. Symposium: Basic research
on nicotine (Paraninfo Room)
| Chairperson: |
Fernando Rodríguez de Fonseca |
| Speakers: |
Rafael Maldonado
Involvement of the endogenous opioid system in nicotine-induced
antinociception, rewarding effects and dependence
Liana Fattore
Baclofen as a putative candidate in the pharmacotherapy
of nicotine abuse: Pre-clinical behavioural and biochemical
evidence
Athina Markou
Group II metabotropic and AMPA/kainate ionotropic glutamate
receptors regulate the deficit in brain reward function associated
with nicotine withdrawal
Sakire Pogun
Sex differences in the central action of nicotine
|
| Objective: |
To review recent advances in the central effects and mechanisms
of action of nicotine |
|
